The identification of a highly prevalent, core genome-encoded SAg that contributes to the pathogenesis of bacteremia, allied to the observation that its function can be neutralized by specific antibodies, suggests that SElW should be considered a component of a S. aureus vaccine targeting invasive infections. The gene discussed is SELENOW; the disease is bacterial infectious disease with sepsis.